These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16267670)

  • 1. Increased nitric oxide (NO) pathway metabolites in the vitreous fluid of patients with rhegmatogenous retinal detachment or diabetic traction retinal detachment.
    Diederen RM; La Heij EC; Deutz NE; Kessels AG; van Eijk HM; Hendrikse F
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):683-8. PubMed ID: 16267670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-Arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients.
    Hattenbach LO; Allers A; Klais C; Koch F; Hecker M
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):213-7. PubMed ID: 10634623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase.
    Coral K; Angayarkanni N; Gomathy N; Bharathselvi M; Pukhraj R; Rupak R
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3607-12. PubMed ID: 19369240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy.
    Yilmaz G; Esser P; Kociok N; Aydin P; Heimann K
    Am J Ophthalmol; 2000 Jul; 130(1):87-90. PubMed ID: 11004264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostanoids in the vitreous of diabetic and nondiabetic human eyes with retinal detachment.
    Naveh N; Belkin M; Ben-Chaim O; Weissman C; Treister G
    Ophthalmic Res; 1990; 22(1):3-11. PubMed ID: 2111530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased glutamate levels in the vitreous of patients with retinal detachment.
    Diederen RM; La Heij EC; Deutz NE; Kijlstra A; Kessels AG; van Eijk HM; Liem AT; Dieudonné S; Hendrikse F
    Exp Eye Res; 2006 Jul; 83(1):45-50. PubMed ID: 16530753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of Inflammatory Cytokines in the Vitreous Fluid from Patients with Rhegmatogenous Retinal Detachment and Their Correlations with Clinical Features.
    Takahashi S; Adachi K; Suzuki Y; Maeno A; Nakazawa M
    Biomed Res Int; 2016; 2016():4256183. PubMed ID: 28074184
    [No Abstract]   [Full Text] [Related]  

  • 11. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment.
    Ogata N; Tombran-Tink J; Nishikawa M; Nishimura T; Mitsuma Y; Sakamoto T; Matsumura M
    Am J Ophthalmol; 2001 Sep; 132(3):378-82. PubMed ID: 11530051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
    Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High subretinal fluid procoagulant activity in rhegmatogenous retinal detachment.
    Ricker LJ; Dieri RA; Beckers GJ; Pels E; Liem AT; Hendrikse F; Kijlstra A; Hemker HC; La Heij EC
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5234-9. PubMed ID: 20435588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy.
    Pinna A; Emanueli C; Dore S; Salvo M; Madeddu P; Carta F
    Ophthalmologica; 2004; 218(4):260-3. PubMed ID: 15258415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
    BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Expression of GDF-15 in the Human Vitreous in the Presence of Retinal Pathologies with an Inflammatory Component.
    Ilhan HD; Bilgin AB; Toylu A; Dogan ME; Apaydin KC
    Ocul Immunol Inflamm; 2016; 24(2):178-83. PubMed ID: 26177355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
    Fokkens BT; Mulder DJ; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    PLoS One; 2017; 12(3):e0173379. PubMed ID: 28264049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy.
    Oku H; Kida T; Sugiyama T; Hamada J; Sato B; Ikeda T
    Retina; 2001; 21(6):647-51. PubMed ID: 11756889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of soluble syndecan-1 in the subretinal fluid and the vitreous of eyes with rhegmatogenous retinal detachment.
    Wang JB; Tian CW; Guo CM; Du HJ; Liu HL; Zhang YJ; Hui YN
    Curr Eye Res; 2008 Jan; 33(1):101-7. PubMed ID: 18214747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between miR-148 Expression in Vitreous and Severity of Rhegmatogenous Retinal Detachment.
    Tsunekawa T; Kaneko H; Takayama K; Hwang SJ; Oishi A; Nagasaka Y; Ye F; Iwase T; Nonobe N; Ueno S; Ito Y; Yasuda S; Matsuura T; Shimizu H; Suzumura A; Kataoka K; Terasaki H
    Biomed Res Int; 2017; 2017():3427319. PubMed ID: 28261609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.